Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: Higher expression of ZAP70 and PKC-β II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN

References

• Gatter K C, Warnke R A. Diffuse large B-cell lymphoma. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid Tissues, E S Jaffe, N L Harris, H Stein, J W Vardiman. IARC Press, Lyon 2001; 171–174
   Google Scholar
• Pileri S A, Dirnhofer S, Went P, Ascani S, Sabattini E, Marafioti T, et al. Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification. Histopathology 2002; 41: 482–509
   PubMed Web of Science ®Google Scholar
• Shaffer A L, Rosenwald A, Staudt L M. Lymphoid malignancies: the dark side of B-cell differentiation. Nat Rev Immunol 2002; 2: 920–932
   PubMed Web of Science ®Google Scholar
• Sanchez-Beato M, Sanchez-Aguilera A, Piris M A. Cell cycle deregulation in B-cell lymphomas. Blood 2003; 101: 1220–1235
   PubMed Web of Science ®Google Scholar
• de Leval L, Harris N L. Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance. Histopathology 2003; 43: 509–528
   PubMed Web of Science ®Google Scholar
• Falini B, Mason D Y. Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukaemia: clinical value of their detection by immunocytochemistry. Blood 2002; 99: 409–426
   PubMed Web of Science ®Google Scholar
• Berglund M, Enblad G, Flordal E, Lui W, Backlin C, Thunberg U, et al. Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization. Mod Pathol 2002; 15: 807–816
   PubMed Web of Science ®Google Scholar
• Alizadeh A A, Eisen M B, Davis R E, Ma C, Lossos I S, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–511
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Wright G, Chan W C, Connors J M, Campo E, Fisher R I, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 1937–1947
   PubMed Web of Science ®Google Scholar
• Wright G, Tan B, Rosenwald A, Hurt E H, Wiestner A, Staudt L M. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2003; 100: 9991–9996
   PubMed Web of Science ®Google Scholar
• Chang C C, McClintock S, Cleveland R P, Trzpuc T, Vesole D H, Logan B, et al. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am J Surg Pathol 2004; 28: 464–470
   PubMed Web of Science ®Google Scholar
• Hans C P, Weisenburger D D, Greiner T C, Gascoyne R D, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2003; 103: 275–282
   PubMed Web of Science ®Google Scholar
• Natkunam Y, Warnke R A, Montgomery K, Falini B, van De Rijn M. Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry. Mod Pathol 2001; 14: 686–694
   PubMed Web of Science ®Google Scholar
• Falini B, Fizzotti M, Pucciarini A, Bigerna B, Marafioti T, Gambacorta M, et al. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 2000; 95: 2084–2092
   PubMed Web of Science ®Google Scholar
• Bai M, Agnantis N J, Skyrlas A, Tsanou E, Kamina S, Galani V, Kanavaros P. Increased Expression of the bcl6 and CD10 proteins is associated with increased apoptosis and proliferation in diffuse large B-cell lymphomas. Mod Pathol 2003; 16: 471–480
   PubMed Web of Science ®Google Scholar
• Martinez-Valdez H, Guret C, de Bouteiller O, Fugier I, Banchereau J, Liu Y J. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. J Exp Med 1996; 183: 971–977
   PubMed Web of Science ®Google Scholar
• Cutrona G, Dono M, Pastorino S, Ulivi M, Burgio V L, Zupo S, et al. The propensity to apoptosis of centrocytes and centroblasts correlates with elevated levels of intracellular myc protein. Eur J Immunol 1997; 27: 234–238
   PubMed Web of Science ®Google Scholar
• Dono M, Burgio V L, Tacchetti C, Favre A, Augliera A, Zupo S, et al. Subepithelial B cells in the human palatine tonsil. I. Morphologic, cytochemical and phenotypic characterization. Eur J Immunol 1996; 26: 2035–2041
   PubMed Web of Science ®Google Scholar
• Armitage J O, Weisenburger D D. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998; 16: 2780–2795
   PubMed Web of Science ®Google Scholar
• Scielzo C, Camporeale A, Geuna M, Alessio M, Poggi A, Zocchi M R, et al. ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage. Leukemia 2006; 20: 689–695
   PubMed Web of Science ®Google Scholar
• Crespo M, Villamor N, Gine E, Muntanola A, Colomer D, Marafioti T, et al. ZAP-70 expression in normal pro/pre B cells, mature B cells, and in B-cell acute lymphoblastic leukemia. Clin Cancer Res 2006; 12: 726–734
   PubMed Web of Science ®Google Scholar
• Ono Y, Kikkawa U T, Ogita K, Fujii T, Kurokawa T, Asaoka Y, et al. Expression and properties of two types of protein kinase C: alternative splicing from a single gene. Science 1987; 236: 1116–1120
   PubMed Web of Science ®Google Scholar
• Policha A, Daneshtalab N, Chen L, Dale L B, Altier C, Khosravani H, et al. Role of angiotensin II type 1A receptor phosphorylation, phospholipase D, and extracellular calcium in isoform-specific protein kinase C membrane translocation responses. J Biol Chem 2006; 281: 26340–26349
   PubMed Web of Science ®Google Scholar
• Shipp M A, Ross K N, Tamayo P, Weng A P, Kutok J L, Aguiar R C, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002; 8: 68–74
   PubMed Web of Science ®Google Scholar
• Hans C P, Weisenburger D D, Greiner T C, Chan W C, Aoun P, Cochran G T, et al. Expression of PKC-β or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma. Mod Pathol 2005; 18: 1377–1384
   PubMed Web of Science ®Google Scholar
• Espinosa I, Briones J, Bordes R, Brunet S, Martino R, Sureda A, et al. Membrane PKC-β 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma. Ann Hematol 2006; 85: 597–603
   PubMed Web of Science ®Google Scholar
• Anzelon A N, Wu H, Rickert R C. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat Immunol 2003; 4: 287–294
   PubMed Web of Science ®Google Scholar
• Uner A H, Saglam A, Han U, Hayran M, Sungur A, Ruacan S. PTEN and p27 expression in mature T-cell and NK-cell neoplasms. Leuk Lymphoma 2005; 46: 1463–1470
   PubMed Web of Science ®Google Scholar
• Shen W H, Balajee A S, Wang J, Wu H, Eng C, Pandolfi P P, et al. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 2007; 128: 157–170
   PubMed Web of Science ®Google Scholar
• Wu C, Sun M, Liu L, Zhou G W. The function of the protein tyrosine phosphatase SHP-1 in cancer. Gene 2003; 306: 1–12
   PubMed Web of Science ®Google Scholar
• Berglund M, Thunberg U, Amini R M, Book M, Roos G, Erlanson M, et al. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis. Mod Pathol 2005; 18: 1113–1120
   PubMed Web of Science ®Google Scholar
• Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844–847
   PubMed Web of Science ®Google Scholar
• Nilsson J, Soderberg O, Nilsson K, Rosen A. Differentiation-associated redox-regulation in human B cell lines from stem cell/pro-B to plasma cell. Immunol Lett 2004; 94: 83–89
   PubMed Web of Science ®Google Scholar
• Berglund M, Thunberg U, Fridberg M, Gjörloff Wingren A, Gullbo J, Leuchowius K J, et al. Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma. Leuk Lymphoma 2007; 48: 1038–1041
   PubMed Web of Science ®Google Scholar
• Amini R M, Berglund M, Rosenquist R, Von Heideman A, Lagercrantz S, Thunberg U, et al. A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma. Leuk Lymphoma 2002; 43: 2179–2189
   PubMed Web of Science ®Google Scholar
• Sambade C, Berglund M, Lagercrantz S, Sallstrom J, Reis R M, Enblad G, et al. U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma. Int J Cancer 2006; 118: 555–563
   PubMed Web of Science ®Google Scholar
• Sambade C, Sallstrom J, Wiklund H J, Enblad G, Kivi S, Gartner F, et al. A novel human B-cell line (U-2904) bearing t(8;14) and t(14;18) translocations. Int J Cancer 1995; 63: 710–715
   PubMed Web of Science ®Google Scholar
• Oken M M, Creech R H, Tormey D C, Horton J, Davis T E, McFadden E T, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649–655
   PubMed Web of Science ®Google Scholar
• Di Florio A, Capurso G, Milione M, Panzuto F, Geremia R, Fave G D, et al. Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells. Endocr Relat Cancer 2007; 14: 111–124
   PubMed Web of Science ®Google Scholar
• Teixeira M R. Recurrent fusion oncogenes in carcinomas. Crit Rev Oncog 2006; 12: 257–271
   PubMedGoogle Scholar
• Tautz L, Pellechia M, Mustelin T. Targeting the PTPome in human disease. Expert Opin Therapeut Targets 2006; 10: 157–177
   PubMed Web of Science ®Google Scholar
• Lossos I S, Alizadeh A A, Diehn M, Warnke R, Thorstenson Y, Oefner P J, et al. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci USA 2002; 99: 8886–8891
   PubMed Web of Science ®Google Scholar
• Gobessi S, Laurenti L, Longo P, Sica S, Leone G, Efremov D. ZAP70 enhances B-cell receptor signalling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukaemia and lymphoma B cells. Blood 2007; 109: 2032–2039
   PubMed Web of Science ®Google Scholar
• Admirand J H, Rassidakis G Z, Abruzzo L V, Valbuena J R, Jones D, Medeiros L J. Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma. Mod Pathol 2004; 17: 954–961
   PubMed Web of Science ®Google Scholar
• Carreras J, Villamor N, Colomo L, Moreno C, Ramon y Cajal S, Crespo M, et al. Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms. J Pathol 2005; 205: 507–513
   PubMed Web of Science ®Google Scholar
• Gimm O, Perren A, Weng L P, Marsh D J, Yeh J J, Ziebold U, et al. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol 2000; 156: 1693–1700
   PubMed Web of Science ®Google Scholar
• Perren A, Komminoth P, Saremaslani P, Matter C, Feurer S, Lee J A, et al. Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol 2000; 157: 1097–1103
   PubMed Web of Science ®Google Scholar
• Li A G, Piluso L G, Cai X, Wei G, Sellers W R, Liu X. Mechanistic insights into maintenance of high p53 acetylation by PTEN. Mol Cell 2006; 23: 575–587
   PubMed Web of Science ®Google Scholar
• Lian Z, Di Cristofano A. Class reunion: PTEN joins the nuclear crew. Oncogene 2005; 24: 7394–7400
   PubMed Web of Science ®Google Scholar
• Paling N RD, Welham M J. Tyrosine phosphatase SHP-1 acts at different stages of development to regulate hematopoiesis. Blood 2005; 105: 4290–4297
   PubMed Web of Science ®Google Scholar